Acute severe mitral regurgitation during first attacks of rheumatic fever: Clinical spectrum, mechanisms and prognostic factors

Journal of Heart Valve Disease

Volumn 14, Issue 4, 2005, Pages 440-446

  Kamblock, Joél ^a   N'Guyen, Lam ^a   Pagis, Bruno ^a   Costes, Philippe ^a   Le Goanvic, Christophe ^a   Lionet, Philippe ^a   Maheu, Benoit ^a   Papouin, Gérard ^a  

^a Centre de Cardiologie du Taaone   (French Polynesia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PRAZOSIN; STEROID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIINFECTIVE AGENT; CARDIOTONIC AGENT; CORTICOSTEROID; DIGITALIS GLYCOSIDE;

ACUTE DISEASE; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART SURGERY; HOSPITAL ADMISSION; HUMAN; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RHEUMATIC FEVER; DOPPLER ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITALIZATION; MITRAL VALVE PROLAPSE; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDITIS; OUTCOME ASSESSMENT; POLYNESIA;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-BACTERIAL AGENTS; CARDIOTONIC AGENTS; DIGITALIS GLYCOSIDES; DIURETICS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE PROLAPSE; MULTIVARIATE ANALYSIS; MYOCARDITIS; OUTCOME ASSESSMENT (HEALTH CARE); PENICILLIN G, BENZATHINE; POLYNESIA; PRAZOSIN; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RHEUMATIC FEVER; SEVERITY OF ILLNESS INDEX;

EID: 33644658414     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Stollerman GH. Rheumatic fever. Lancet 1997;349:935-942
2. Marcus R, Sareli P, Pocock W, Barlow J. The spectrum of severe rheumatic mitral valve disease in a developing country. Ann Intern Med 1994;120:177-183
3. Eisenberg M. Rheumatic heart disease in the developing world: Prevalence, prevention, and control. Eur Heart J 1993;14:122-128
4. Vasan R, Shrivastava S, Vijaya Kumar K, et al. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 1996;94:73-82
5. Tompkins DG, Boxerbaum B, Liebman J. Long term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972;45:543-551
6. Marcus RH, Sareli P, Pocock WA, et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am J Cardiol 1989;63:577-584
7. Albert D, Harel L, Karrison T. The treatment of rheumatic carditis: A review and meta-analysis. Medecine 1995;74:1-12
8. Kamblock J, Payot L, Iung B, et al. Does rheumatic myocarditis really exist? Systematic study with echocardiography and cardiac troponin I blood levels. Eur Heart J 2003;24:855-862
9. Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as the cause of left ventricular dilation in active rheumatic carditis. J Am Coll Cardiol 1993;22:826-829
10. Yau TM, Farag El-Ghoneimi YA, Armstrong S, et al. Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg 2000;119:53-60
11. Duran CM, Gometza B, Saad E. Valve repair in rheumatic mitral disease: An unsolved problem. J Card Surg 1994;9(suppl.2):282-285
12. Kuwaki K, Kiyofumi M, Tsukamoto M, et al. Early and late results of mitral valve repair for mitral valve regurgitation: Significant risk factors of reoperation. J Cardiovasc Surg 2000;41:187-192
13. Al Jubair KA, Jaralla A, Fadala M, et al. Repair of the mitral valve because of pure rheumatic mitral valvular incompetence in the young. Cardiol Young 1998;1:90-93
14. Kalangos A Beghetti M, Vala D, et al. Anterior mitral leaflet prolapse as a primary cause of pure rheumatic mitral insufficiency. Ann Thorac Surg 2000;69:755-761
15. Antunes MJ, Magalhaes MP, Colsen PR, et al. Valvuloplasty of rheumatic mitral valve disease. J Thorac Cardiovasc Surg 1987;94:44-56
16. Duran CM, Gometza B, Balasundaram S, et al. A feasibility study of valve repair in rheumatic mitral regurgitation. Eur Heart J 1991;12(suppl.B):34-38
17. Chauvaud S, Fuzellier JF, Berrebi A, Deloche A, Fabiani JN, Carpentier A. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation 2001;104(12 Suppl.1):I12-I15
18. Committee on Rheumatic Fever and Bacterial Endocarditis of the American Heart Association. Jones' criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation 1984;69:203A-208A
19. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council of Cardiovascular Disease in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever: Jones' criteria, 1992 update. JAMA 1992;268:2069-2073
20. Narula J, Chandrasekhar Y, Rahimtoola MB. Diagnosis of active rheumatic carditis. Circulation 1999;100:1576-1581
21. Kamblock J, Papouin G, Costes P. Prise en charge du rhumatisme articulaire aigu en Polynésie Française. Med Trop 1996;56:29S-30S
22. Helmcke F, Nanda N, Hsiung M, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-183
23. Tribouilloy C, Shen W, Slama M, et al. Non-invasive measurement of the regurgitant fraction by pulsed Doppler echocardiography in isolated pure mitral regurgitation. Br Heart J 1991;66:290-294
24. Bargigia G, Tronconi L, Shan D, et al. A new method for quantification of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice. Circulation 1991;84:1481-1489
25. Tribouilloy C, Shen W, Quere J, et al. Assessment of severity of mitral regurgitation by measuring regurgitant jet width at its origin with trans esophageal Doppler color flow imaging. Circulation 1992;85:1248-1251
26. Zoghbi W, Enriquez Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802
27. King DH, Smith O, Huhta JC, Gutgesell HP. Mitral and tricuspid annular diameter in normal children determined by two-dimensional echocardiography. Am J Cardiol 1985;55:787-789
28. Kampmann C, Wiethoff CM, Wenzel A, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000;83:667-672
29. Feigenbaum H. Echocardiography in the management of mitral valve prolapse. Aust N Z J Med 1992;22:550-555
30. Levine RA, Triulzi MO, Harrigan P, Weyman AE. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation 1987;75:756-767
31. Stewart WJ, Currie PJ, Salcedo EE, et al. Evaluation of mitral leaflet motion by echocardiography and jet direction by Doppler color flow mapping to determine the mechanism of mitral regurgitation. J Am Coll Cardiol 1992;20:1353-1361
32. Lembo N, Dell'Italia L, Crawford M, et al. Mitral valve prolapse in patients with prior rheumatic fever. Circulation 1988;77:830-836
33. Wu MH, Lue HC, Wang JK, Wu JM. Implications of mitral valve prolapse in children with rheumatic mitral regurgitation. J Am Coll Cardiol 1999;23:1199-1203
34. De Moor MMA, Lachman PI, Human DG. Rupture of tendinous chords during acute rheumatic carditis in young children. Int J Cardiol 1986;12:353-357
35. Minich L, Tani L, Veasy G. Role of echocardiography in the diagnosis and follow up evaluation of rheumatic carditis. In: Narula J (ed.). Rheumatic Fever. American Registry of Pathology Armed Forces Institute of Pathology, 1999:308
36. Gillenov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998;116:734-743
37. Gaasch W, Aurigemma G. Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation. J Am Coll Cardiol 2002;39:1380-1383
38. Pisacane C, Pacileo G, Santoro G, et al. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: Role of angiotensin-converting enzyme inhibitor therapy. Ital Heart J 2001;2:100-106
39. Sastrosubroto H, Soeroso S, Indrasanto E. Captopril treatment in rheumatic heart disease with congestive heart failure. A preliminary report. Paediatr Indones 1989;29(9-10):209-214
40. Schön HR, Schröter G, Barthel P, et al. Quinapril therapy in patients with chronic mitral regurgitation. J Heart Valve Dis 1994;3:303-312
41. Schön HR. Hemodynamic and morphologic changes after long-term ACE inhibition in patients with chronic valvular regurgitation. J Hypertens 1994;12(suppl.4):S95-S104
42. Host U, Kelbaek H, Hildebrandt P, et al. Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 1997;80:655-658
43. Tischler MD, Rowan M, LeWinter MM. Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 1998;82:242-245
44. Calabro R, Pisacane C, Pacileo G, et al. Hemodynamic effects of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation. Am Heart J 1999;138:955-961
45. Mori Y, Nakazawa M, Tomimatsu H. Long-term effect of ACE inhibitor in volume overload heart during growth: A controlled pilot study. J Am Coll Cardiol 2000;36:270-275
46. Perry GJ, Wei CC, Hankes GH, et al. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. J Am Coll Cardiol 2002;39:1374-1379
47. Nemoto S, Hamawaki M, De Freitas G, et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002;40:149-154